| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/27/2011 | EP2314629A1 Recombinant production of mixtures of antibodies |
| 04/27/2011 | EP2314628A1 Anti-cd27 antibody |
| 04/27/2011 | EP2314625A1 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 04/27/2011 | EP2314624A2 Human antibody molecules for IL-13 |
| 04/27/2011 | EP2314622A1 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 04/27/2011 | EP2314621A1 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/27/2011 | EP2314620A1 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/27/2011 | EP2314612A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314611A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314610A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314607A1 Polypeptides involved in regulation of sugar and lipid metabolism and methods of use VIII |
| 04/27/2011 | EP2314606A1 Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use VIII |
| 04/27/2011 | EP2314605A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/27/2011 | EP2314602A1 Improved expression systems with SEC-system secretion |
| 04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |
| 04/27/2011 | EP2314596A2 DNA-Polymerase blends and mutant DNA polymerases |
| 04/27/2011 | EP2314595A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/27/2011 | EP2314321A1 Formulations comprising antisense nucleotides to connexins |
| 04/27/2011 | EP2314317A2 Anti-glypican 3 antibody |
| 04/27/2011 | EP2314316A1 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 04/27/2011 | EP2314308A1 Use of microproteins as tryptase inhibitors |
| 04/27/2011 | EP2314306A1 Biological pacemaker |
| 04/27/2011 | EP2313784A1 Immunotherapeutic method |
| 04/27/2011 | EP2313527A2 Lateral flow nucleic acid detector |
| 04/27/2011 | EP2313513A2 Methods and compositions for improving the production of products in microorganisms |
| 04/27/2011 | EP2313512A2 Transformation of glycerol and cellulosic materials into high energy fuels |
| 04/27/2011 | EP2313511A1 Senescene cells and methods for its production |
| 04/27/2011 | EP2313510A2 Glutamate decarboxylase (gad) transgenic plants with enhanced nitrogen uptake and utilisation |
| 04/27/2011 | EP2313509A1 Plants producing 2n pollen |
| 04/27/2011 | EP2313508A1 Plants having enhanced yield-related traits and a method for making the same |
| 04/27/2011 | EP2313507A2 High throughput screening method and use thereof to identify a production platform for a multifunctional binding protein |
| 04/27/2011 | EP2313506A1 Antagonists of nr2f6 for augmenting the immune response |
| 04/27/2011 | EP2313505A2 Compositions and methods for inhibiting expression of tgf-beta receptor genes |
| 04/27/2011 | EP2313503A2 Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof |
| 04/27/2011 | EP2313500A1 Modified family 6 glycosidases with altered substrate specificity |
| 04/27/2011 | EP2313497A1 Improved production host cell lines |
| 04/27/2011 | EP2313495A1 Prokaryotic xylose isomerase for the construction of xylose fermenting yeasts |
| 04/27/2011 | EP2313491A2 Methods, compositions and systems for biosynthetic bio production of 1,4-butanediol |
| 04/27/2011 | EP2313490A2 New streptomyces beta-vulgaris strain, culture filtrate, derived active compounds and use thereof in the treatment of plants |
| 04/27/2011 | EP2313431A2 Long-acting interferons and derivatives thereof and methods thereof |
| 04/27/2011 | EP2313429A1 Msp-1 protein preparations from plasmodium |
| 04/27/2011 | EP2312934A2 Stress tolerant transgenic plants |
| 04/27/2011 | EP2039367B1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 04/27/2011 | EP1942985B1 Methods for reducing blood pressure |
| 04/27/2011 | EP1930436B1 Vector for delivering target substance into nucleus or cell |
| 04/27/2011 | EP1910538B1 Methods for synthesis of encoded libraries |
| 04/27/2011 | EP1856168B1 Sample lysis and coating of reaction surface |
| 04/27/2011 | EP1833967B1 Conserved hbv and hcv sequences useful for gene silencing |
| 04/27/2011 | EP1820856B1 Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant |
| 04/27/2011 | EP1819830B1 Methods for antibody engineering |
| 04/27/2011 | EP1802750B1 Phytases |
| 04/27/2011 | EP1792985B1 Cell fusion promoter and utilization of the same |
| 04/27/2011 | EP1713828B1 Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide |
| 04/27/2011 | EP1682665B1 Use of fibroblast growth factor fragments |
| 04/27/2011 | EP1551977B1 Selective, local activation of members of the tnf ligand family of systemically inactive non-antibody tnf ligand fusion proteins |
| 04/27/2011 | EP1539233B1 Super humanized antibodies |
| 04/27/2011 | EP1532174B1 Anti-igf-i receptor antibody |
| 04/27/2011 | EP1461619B1 Improved structured-functional bonding matrices for biomolecules |
| 04/27/2011 | EP1456394B2 Methods of using improved polymerases |
| 04/27/2011 | EP1419175B1 Replikin peptides and uses thereof |
| 04/27/2011 | EP1368373B1 Environmentally regulated genes, involved in the virulence of streptococcus suis |
| 04/27/2011 | EP1317470B1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate tumor therapy |
| 04/27/2011 | EP1297163B1 Recombinant constructs and their use in reducing gene expression |
| 04/27/2011 | EP1272633B1 Compositions and methods for dendritic cell-based immunotherapy |
| 04/27/2011 | EP1257292B1 Use of il-18 inhibitors |
| 04/27/2011 | EP1118660B1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/27/2011 | EP1105486B1 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
| 04/27/2011 | EP1068311B1 Methods and means for obtaining modified phenotypes |
| 04/27/2011 | EP0972031B1 Procollagen assembly |
| 04/27/2011 | CN1871356B Retroviral virus vectors for delivery of interfering rna |
| 04/27/2011 | CN1845995B Chimeric antigens for breaking host tolerance to foreign antigens |
| 04/27/2011 | CN1798836B Methods for preventing gluconoylation of proteins |
| 04/27/2011 | CN1515671B Agrobacterium mediated plant nonselective gene conversion method |
| 04/27/2011 | CN102037140A Method for determination of DNA methylation |
| 04/27/2011 | CN102037139A Method for determination of DNA methylation |
| 04/27/2011 | CN102037137A RNA in situ hybridization |
| 04/27/2011 | CN102037136A Products and their use for the diagnosis, prevention, and/or care of human and/or animal pathologies characterised by the anomalous deposition of beta-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 04/27/2011 | CN102037127A Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same |
| 04/27/2011 | CN102037126A Method and gene for imparting or enhancing nonspecific adherence and/or aggregability to microorganism |
| 04/27/2011 | CN102037125A Use of rice polypeptides/nucleic acids for plant improvement |
| 04/27/2011 | CN102037124A hERG mutants and uses thereof |
| 04/27/2011 | CN102037123A Compositions and use of epas1 inhibitors |
| 04/27/2011 | CN102037120A Zymomonas with improved xylose utilization |
| 04/27/2011 | CN102037018A Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody |
| 04/27/2011 | CN102037014A Biomarkers |
| 04/27/2011 | CN102036683A Cytotoxic composition |
| 04/27/2011 | CN102036681A Recombinant viral vectors and vaccine composition for leishmaniasis |
| 04/27/2011 | CN102033056A Method for evaluating anti-cancer drug inhibiting aggregation of membrane protein receptors |
| 04/27/2011 | CN102031314A Primer and probe sequence for human metapneumovirus nucleonic acid detection |
| 04/27/2011 | CN102031313A RT-PCR (reverse transcription-polymerase chain reaction) method for detecting the infection reality of host by arabis mosaic virus, bean yellow mosaic virus and lily symptomless virus |
| 04/27/2011 | CN102031311A Gene chip for detecting 6 viruses of zoonosis-borne diseases and application thereof |
| 04/27/2011 | CN102031305A Recombinant containing influenza A specific promoter and application thereof |
| 04/27/2011 | CN102031300A DNA probe and gene chip for detecting aspergillus terreus and application thereof |
| 04/27/2011 | CN102031299A DNA probe for detecting Aspergillus niger, gene chip and application thereof |
| 04/27/2011 | CN102031298A DNA (deoxyribose nucleic acid) probe and gene chip for detecting rhizomucor pusillus and applications thereof |
| 04/27/2011 | CN102031297A DNA probe and gene chip for detecting candida kefyr and application of DNA probe and gene chip |
| 04/27/2011 | CN102031296A DNA probe for detecting aspergillus nidulans, gene chip and application thereof |
| 04/27/2011 | CN102031295A DNA probe for detecting rhizopus oligosporus, gene chip and application thereof |
| 04/27/2011 | CN102031294A DNA probe and gene chip for detecting trichosporon asahii and application thereof |
| 04/27/2011 | CN102031293A DNA probe and gene chip for detecting Candida rugosa and application thereof |